These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3299121)

  • 21. Metacarpal cortical thickness in uremic patients on regular hemodialysis.
    Del Rio A; Rico H; Carrera F; Torrente J; D'Ocón MT; Espinós D
    Nephron; 1978; 22(4-6):354-60. PubMed ID: 740097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc metabolism in uremia.
    Mahajan SK; Prasad AS; Rabbani P; Briggs WA; McDonald FD
    J Lab Clin Med; 1979 Nov; 94(5):693-8. PubMed ID: 501198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological changes of the liver in uremic patients treated with chronic hemodialysis--laparoscopic observations and light- and electron-microscopic studies.
    Kawata S; Seki K; Minami Y; Kameda Y; Nishikawa M; Tarui S; Yoshitake S; Nishiuchi M; Oda T
    Gastroenterol Jpn; 1980; 15(3):212-20. PubMed ID: 7399221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis].
    Redaelli B; Salvadeo A; Ponticelli C; Imbasciati E; Graziani G
    Minerva Nefrol; 1967; 14(4):158-62. PubMed ID: 5607555
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemorheological changes induced by uremia. Effects of hemodialysis].
    Delsignore R; David S; Francia MT; Bottazzi G; Crotti G
    Ric Clin Lab; 1985; 15 Suppl 1():335-45. PubMed ID: 4035225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of pancreatic disease in chronic renal failure.
    Avram MM
    Nephron; 1977; 18(1):68-71. PubMed ID: 846627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.
    De Marchi S; Cecchin E; Villalta D; Tesio F
    Clin Nephrol; 1987 Apr; 27(4):189-98. PubMed ID: 3581526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gastrointestinal tract in uremic patients on long-term hemodialysis.
    Milito G; Taccone-Gallucci M; Brancaleone C; Nardi F; Cesca D; Boffo V; Casciani CU
    Kidney Int Suppl; 1985 Dec; 17():S157-60. PubMed ID: 3867787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Insulin resistance in the uremic patient: effects of hemodialysis].
    Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coagulation factor VII levels in uremic patients and theirs influence factors].
    Fang J; Xia LH; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis.
    Niwa T; Yoshizumi H; Emoto Y; Miyazaki T; Hashimoto N; Takeda N; Tatematsu A; Maeda K
    Clin Chem; 1991 Feb; 37(2):159-61. PubMed ID: 1825184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test.
    Goch J; Birgegård G; Danielson BG; Wikström B
    Nephron; 1996; 73(3):403-6. PubMed ID: 8832597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uremia impairs blood dendritic cell function in hemodialysis patients.
    Lim WH; Kireta S; Russ GR; Coates PT
    Kidney Int; 2007 Jun; 71(11):1122-31. PubMed ID: 17377508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis.
    Frangos-Plemenos M; Agroyannis B; Koutsicos D; Tzanatos-Exarchou H; Logothetis E; Sarris E; Kaya S; Yatzidis H
    Int J Artif Organs; 1987 May; 10(3):195-8. PubMed ID: 3610372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Periodic hemodialysis in non-selected patients with chronic terminal uremia. Results of a study made in a Northeastern Lombardia District Hospital with special regard to survival and influence of age (1573 cases of extracorporeal dialysis in 22 patients)].
    Gargano N
    Minerva Med; 1973 Sep; 64(63):3283-91. PubMed ID: 4774224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.